PEPentwater Capital Management LP
Institutional investor · Portfolio as of Q3 2020
Top Holdings219 positions
| 5.7M | $1.9B | 24.6% | — | — | — | Increased — | |
Tiffany & Co | 4.4M | $512.5M | 6.6% | — | — | 4 qtrssince 2019-Q4 | Increased 79 |
SPDR S&P 500 ETF Trust | 1.5M | $493.5M | 6.4% | $253.84 | +21.68% | 3 qtrssince 2020-Q1 | Increased 78 |
Maxim Integrated Products Inc | 7.1M | $479.6M | 6.2% | — | — | 1 qtr | New 97 |
IMMUNOMEDICS INC | 3.9M | $333.3M | 4.3% | — | — | 1 qtr | New 86 |
| 2.6M | $305.9M | 4.0% | — | — | — | Increased — | |
PG&E Corp | 31.5M | $296M | 3.8% | $10.96 | -15.30% | 7 qtrssince 2019-Q1 | Decreased 0 |
GrubHub Inc | 2.5M | $181.5M | 2.3% | — | — | 2 qtrssince 2020-Q2 | Increased 84 |
Taubman Centers Inc | 5M | $166.8M | 2.2% | — | — | 3 qtrssince 2020-Q1 | Increased 68 |
The Charles Schwab Corp | 4M | $158.5M | 2.1% | $50.95 | -99.00% | 4 qtrssince 2019-Q4 | Decreased 0 |
Turquoise Hill Resources Ltd | 185.8M | $156.7M | 2.0% | — | — | 7 qtrssince 2019-Q1 | Increased 52 |
CoreLogic Inc/United States | 2.3M | $156.6M | 2.0% | — | — | 1 qtr | New 78 |
Varian Medical Systems Inc | 800,000 | $137.6M | 1.8% | — | — | 1 qtr | New 69 |
MOMENTA PHARMACEUTICALS INC | 2.3M | $123.2M | 1.6% | — | — | 1 qtr | New 69 |
| 3.2M | $107.2M | 1.4% | — | — | — | Increased — | |
VICI Properties Inc | 4.6M | $106.5M | 1.4% | $14.86 | +19.70% | 3 qtrssince 2020-Q1 | Decreased 0 |
ADVANCED DISP SVCS INC DEL | 3.3M | $99.8M | 1.3% | — | — | 6 qtrssince 2019-Q2 | Increased 63 |
ACACIA COMMUNICATIONS INC | 1.5M | $98.8M | 1.3% | — | — | 4 qtrssince 2019-Q4 | Decreased 0 |
Aimmune Therapeutics Inc | 2.5M | $86.2M | 1.1% | — | — | 1 qtr | New 68 |
| 38.1M | $85.7M | 1.1% | — | — | 4 qtrssince 2019-Q4 | Decreased 0 |
Pentwater Capital Management LP manages $7.7B across 219 positions as of Q3 2020. Top holdings: SPDR S&P 500 ETF TR puts (24.6%), TIF (6.6%), SPY (6.4%). Fund DNA: Momentum Trader. HoldingsIntel Score: 2/5.0.
Active quarter - 80 new positions, 28 exits, 37 increased. Top move: MXIM (NEW, conviction 97). Portfolio: $7.7B across 219 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR